Related references
Note: Only part of the references are listed.The complexity of chronic kidney disease-mineral and bone disorder across stages of chronic kidney disease
Fabiana G. Graciolli et al.
KIDNEY INTERNATIONAL (2017)
Effect of Calcitriol on FGF23 Level in Healthy Adults and its Dependence on Phosphate Level
Effrosyni Georgiadou et al.
IN VIVO (2017)
Sclerostin as a new key factor in vascular calcification in chronic kidney disease stages 3 and 4
Wei Lv et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2016)
PPARγ and Wnt Signaling in Adipogenic and Osteogenic Differentiation of Mesenchymal Stem Cells
Zongyi Yuan et al.
CURRENT STEM CELL RESEARCH & THERAPY (2016)
Sclerostin Serum Levels and Vascular Calcification Progression in Prevalent Renal Transplant Recipients
P. Evenepoel et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Bone Disease in CKD: A Focus on Osteoporosis Diagnosis and Management
Paul D. Miller
AMERICAN JOURNAL OF KIDNEY DISEASES (2014)
Roles of Parathyroid Hormone (PTH) Receptor and Reactive Oxygen Species in Hyperlipidemia-Induced PTH Resistance in Preosteoblasts
Xin Li et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2014)
Association between Parathyroid Hormone Levels and Inflammatory Markers among US Adults
Shih-Ping Cheng et al.
MEDIATORS OF INFLAMMATION (2014)
Long-Term Cholecalciferol Administration in Hemodialysis Patients: A Single-Center Randomized Pilot Study
Mariusz Mieczkowski et al.
MEDICAL SCIENCE MONITOR (2014)
Bone Alkaline Phosphatase in CKD-Mineral Bone Disorder
Sunita Sardiwal et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2013)
PTH-A Particularly Tricky Hormone: Why Measure It at All in Kidney Patients?
Giorgia Garrett et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
Cholecalciferol in haemodialysis patients: a randomized, double-blind, proof-of-concept and safety study
Pierre Delanaye et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2013)
Repression of osteocyte Wnt/β-catenin signaling is an early event in the progression of renal osteodystrophy
Yves Sabbagh et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
Osteoblastogenesis regulation signals in bone remodeling
C. Zuo et al.
OSTEOPOROSIS INTERNATIONAL (2012)
Wnt Signaling in Bone Development and Disease: Making Stronger Bone with Wnts
Jean B. Regard et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2012)
Effects of an Oleaginous Calcitriol on Changes in Plasma Calcitriol, Calcium and Bone Metabolic Markers in Dairy Cows
Danil Kim et al.
JOURNAL OF VETERINARY MEDICAL SCIENCE (2011)
Acute-phase proteins: As diagnostic tool
Sachin Jain et al.
JOURNAL OF PHARMACY AND BIOALLIED SCIENCES (2011)
Reciprocal Control of 1,25-Dihydroxyvitamin D and FGF23 Formation Involving the FGF23/Klotho System
Dominique Prie et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Wnt10b Deficiency Results in Age-Dependent Loss of Bone Mass and Progressive Reduction of Mesenchymal Progenitor Cells
Jennifer R. Stevens et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
T Lymphocytes Amplify the Anabolic Activity of Parathyroid Hormone through Wnt10b Signaling
Masakazu Terauchi et al.
CELL METABOLISM (2009)
1-Alpha, 25-dihydroxy vitamin D3 inhibits osteoclastogenesis through IFN-beta-dependent NFATc1 suppression
Sadaoki Sakai et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2009)
Association Analysis of WNT10B With Bone Mass and Structure Among Individuals of African Ancestry
Joseph M. Zmuda et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2009)
Wnt and PPARγ signaling in osteoblastogenesis and adipogenesis
Ichiro Takada et al.
NATURE REVIEWS RHEUMATOLOGY (2009)
Wnt signaling and skeletal development
Fei Liu et al.
CELLULAR SIGNALLING (2008)
Wnt10b increases postnatal bone formation by enhancing osteoblast differentiation
Christina N. Bennett et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2007)
Metabolism of vitamin D3 in human osteoblasts:: Evidence for autocrine and paracrine activities of 1α,25-dihydroxyvitamin D3
Gerald J. Atkins et al.
BONE (2007)
Evidence for auto/paracrine actions of vitamin D in bone:: 1α-hydroxylase expression and activity in human bone cells
M. van Driel et al.
FASEB JOURNAL (2006)
c-Fos protein as a target of anti-osteoclastogenic action of vitamin D, and synthesis of new analogs
H Takasu et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Wnt/β-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis
TF Day et al.
DEVELOPMENTAL CELL (2005)
Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis:: A paired biopsy study
DW Dempster et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2001)
Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis.
RM Neer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Share Paper
